Budapest, Hungary: September 24th, 2007. ThalesNano Inc., a leading developer and manufacturer of flow chemistry, flow reactor technology, and hydrogenation technology solutions, announced today that it had continued to expand globally by opening a subsidiary in the United Kingdom and by signing distributor agreements in Scandinavia, Italy, and India.
Building its own subsidiary reflects ThalesNano’s commitment to bridging closer ties with its customers and expanding operations globally; it is intended to enhance activities in particular towards the chemical and pharmaceutical sectors, and to reinforce visibility. The UK representatives will bring both added value in operational terms and flexibility for customers.
Alex Drijver, CFO commented: “Chemists will have a local point of contact for advice on the most up-to-date chemistry technologies and solutions. ThalesNano Inc. was already operating successfully through a distributor company in the UK and can now strengthen and consolidate its position with help of its local team of professionals. The UK is a strategic market for the company’s growth, as the country’s R&D spending is the largest within Europe and has the most developed and innovative pharmaceutical and chemical industry. In this way, ThalesNano Inc. can effectively support UK customers at all times with the necessary technology knowledge.”
The new UK ThalesNano team replaces former distributor Asynt Inc., with whom the company’s contract expired in September. The Danish distributor company, Biolab A/S is taking over customers from Asynt Inc. in the Scandinavian region. While in Italy, Stepbio S.R.L. is the new distributor of ThalesNano products.
As a result of ThalesNano’s global expansion, and as a response to the demand for its products and technologies from India, the company has started its operation through cooperation with Inkarp Instruments Pvt. Ltd.
Dr. Ferenc Darvas, president and chairman commented: „The development and growth of both ThalesNano’s sales team and the distributor network comes two years after the initial launch of the award winning H-Cube®, which is rapidly becoming the standard for performing hydrogenation reactions in research laboratories.”
For more information please visit www.thalesnano.com
About ThalesNano Inc.:
ThalesNano Inc. is a technology-intensive company that provides solutions for leading pharmaceutical and biotechnology companies from all over the world. It is specialized in developing and providing microscale flow instruments for chemistry, by exploiting the benefits of combining microfluidics, mezofluidics or nanotechnology with flow chemistry.
The award winning development, H-Cube®, has been recognized as one of the 100 most technologically significant and innovative new products of 2005 by R&D Magazine is the first in a new wave of continuous-flow hydrogenation reactors.
Contact: Dr. Laszlo Urge, CEO e-mail: sales@thalesnano.com, Carl Jones: e-mail: flowchemistry@thalesnano.com
